Eventide Asset Management, LLC Collegium Pharmaceutical, Inc Transaction History
Eventide Asset Management, LLC
- $4.71 Billion
- Q1 2025
A detailed history of Eventide Asset Management, LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Eventide Asset Management, LLC holds 2,639,547 shares of COLL stock, worth $82.1 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
2,639,547
Previous 2,638,702
0.03%
Holding current value
$82.1 Million
Previous $75.6 Million
4.22%
% of portfolio
1.67%
Previous 1.45%
Shares
12 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.1MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$180 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$93.3 Million2.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$69.9 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$50.8 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.62MShares$50.3 Million0.08% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...